Pharmalittle: Pharma lobbies Congress on global tax proposal
In an apparent victory for Purdue Pharma, preliminary voting shows most creditors are in favor of its controversial bankruptcy plan.
Related Articles
Pharmalittle: We’re reading about Lilly buying a plant, a Pfizer antibiotic, and more
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
Pharmalittle: We’re reading about an OptumRx contract, 340B dispute resolution, and more
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth’s OptumRx unit will not be renewed after they expire in June.
Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Pharmalittle: We’re reading about plans for generic Wegovy, cough syrup warnings, and more
Biocon is developing a generic version of Novo Nordisk’s Wegovy and is prepared to conduct a clinical trial next year if needed.
Pharmalittle: We’re reading about BIO’s China challenge, Zepbound shortages, and more
BIO’s about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and…
Pharmalittle: We’re reading about Lilly’s Zepbound for sleep apnea, the FDA budget, and more
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
Pharmalittle: We’re reading about CVS and Humira biosimilars, Schumer’s broken insulin promise, and more
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week…
Pharmalittle: We’re reading about a J&J cough syrup, a Pfizer and Moderna patent suit, and more
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
Colorado lawmakers revise effort to exempt rare disease drugs from state cost caps
Colorado lawmakers are abandoning a bill that would have required a new state board — chartered with setting caps for the cost of medicines — to…
Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.